View in EDS HTML Full Text PDF Full Text

Neutralizing antibody PR8-23 targets the footprint of the sialoglycan receptor binding site of H1N1 hemagglutinin.

Saved in:
Bibliographic Details
Title: Neutralizing antibody PR8-23 targets the footprint of the sialoglycan receptor binding site of H1N1 hemagglutinin.
Authors: Yan L; Central Laboratory,  Shaanxi Provincial People's Hospital, Xi'an, China.; Research Center of Cell Immunological Engineering and Technology of Shaanxi Province, Xi'an, China., Sun L; Central Laboratory,  Shaanxi Provincial People's Hospital, Xi'an, China.; Research Center of Cell Immunological Engineering and Technology of Shaanxi Province, Xi'an, China., Guo C; Central Laboratory,  Shaanxi Provincial People's Hospital, Xi'an, China.; Research Center of Cell Immunological Engineering and Technology of Shaanxi Province, Xi'an, China., Li L; Department of Urology, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro-Urological Clinical Center, The Second Hospital of Lanzhou University, Lanzhou, China., Sun J; Central Laboratory,  Shaanxi Provincial People's Hospital, Xi'an, China.; Research Center of Cell Immunological Engineering and Technology of Shaanxi Province, Xi'an, China., Huang X; Central Laboratory,  Shaanxi Provincial People's Hospital, Xi'an, China.; Research Center of Cell Immunological Engineering and Technology of Shaanxi Province, Xi'an, China., Zhao P; Central Laboratory,  Shaanxi Provincial People's Hospital, Xi'an, China.; Research Center of Cell Immunological Engineering and Technology of Shaanxi Province, Xi'an, China., Xie X; College of Life Sciences, Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi'an, China.; Department of Translational Medicine, Institute of Integrated Medical Information, Xi'an, China., Hu J; Central Laboratory,  Shaanxi Provincial People's Hospital, Xi'an, China.; Research Center of Cell Immunological Engineering and Technology of Shaanxi Province, Xi'an, China.
Source: Journal of medical virology [J Med Virol] 2021 Jun; Vol. 93 (6), pp. 3508-3515. Date of Electronic Publication: 2021 Feb 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9071 (Electronic) Linking ISSN: 01466615 NLM ISO Abbreviation: J Med Virol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33410516
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neutralizing antibody PR8-23 targets the footprint of the sialoglycan receptor binding site of H1N1 hemagglutinin.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yan+L%22">Yan L</searchLink>; Central Laboratory,  Shaanxi Provincial People's Hospital, Xi'an, China.; Research Center of Cell Immunological Engineering and Technology of Shaanxi Province, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Sun+L%22">Sun L</searchLink>; Central Laboratory,  Shaanxi Provincial People's Hospital, Xi'an, China.; Research Center of Cell Immunological Engineering and Technology of Shaanxi Province, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Guo+C%22">Guo C</searchLink>; Central Laboratory,  Shaanxi Provincial People's Hospital, Xi'an, China.; Research Center of Cell Immunological Engineering and Technology of Shaanxi Province, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Li+L%22">Li L</searchLink>; Department of Urology, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro-Urological Clinical Center, The Second Hospital of Lanzhou University, Lanzhou, China.<br /><searchLink fieldCode="AU" term="%22Sun+J%22">Sun J</searchLink>; Central Laboratory,  Shaanxi Provincial People's Hospital, Xi'an, China.; Research Center of Cell Immunological Engineering and Technology of Shaanxi Province, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Huang+X%22">Huang X</searchLink>; Central Laboratory,  Shaanxi Provincial People's Hospital, Xi'an, China.; Research Center of Cell Immunological Engineering and Technology of Shaanxi Province, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Zhao+P%22">Zhao P</searchLink>; Central Laboratory,  Shaanxi Provincial People's Hospital, Xi'an, China.; Research Center of Cell Immunological Engineering and Technology of Shaanxi Province, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Xie+X%22">Xie X</searchLink>; College of Life Sciences, Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi'an, China.; Department of Translational Medicine, Institute of Integrated Medical Information, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Hu+J%22">Hu J</searchLink>; Central Laboratory,  Shaanxi Provincial People's Hospital, Xi'an, China.; Research Center of Cell Immunological Engineering and Technology of Shaanxi Province, Xi'an, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227705876%22">Journal of medical virology</searchLink> [J Med Virol] 2021 Jun; Vol. 93 (6), pp. 3508-3515. <i>Date of Electronic Publication: </i>2021 Feb 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7705876 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-9071 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201466615%22">01466615 </searchLink><i>NLM ISO Abbreviation: </i>J Med Virol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33410516
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/jmv.26779
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3508
    Titles:
      – TitleFull: Neutralizing antibody PR8-23 targets the footprint of the sialoglycan receptor binding site of H1N1 hemagglutinin.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yan L
      – PersonEntity:
          Name:
            NameFull: Sun L
      – PersonEntity:
          Name:
            NameFull: Guo C
      – PersonEntity:
          Name:
            NameFull: Li L
      – PersonEntity:
          Name:
            NameFull: Sun J
      – PersonEntity:
          Name:
            NameFull: Huang X
      – PersonEntity:
          Name:
            NameFull: Zhao P
      – PersonEntity:
          Name:
            NameFull: Xie X
      – PersonEntity:
          Name:
            NameFull: Hu J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2021 Jun
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1096-9071
          Numbering:
            – Type: volume
              Value: 93
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Journal of medical virology
              Type: main
ResultId 1